FDA Urged To Draft Informed Consent Forms For Off-Label Prescribing

FDA should draft sample informed consent forms for physicians to use when prescribing drugs off-label and should better educate consumers on what it means when a drug's benefits outweigh its risks, a leading public health researcher and advocate for safe and effective medical treatments said. The advocate hopes these issues will come up at a June 15 Safe Use Symposium planned by FDA as part of its effort to decrease the nearly 1.5 million preventable adverse drug events that occur...